| 000 | 00000nam 2200000zi 4500 |
| 001 | 9.919143 |
| 003 | CaOODSP |
| 005 | 20250218135237 |
| 006 | m o d f |
| 007 | cr cn||||||||| |
| 008 | 230113t20222022onc ob f000 0 eng d |
| 020 | |a9780660470818 |
| 040 | |aCaOODSP|beng|erda|cCaOODSP |
| 043 | |an-cn--- |
| 086 | 1 |aIu37-37/2023E-PDF |
| 245 | 00|aPost-COVID-19 condition in Canada : |bwhat we know, what we don't know, and a framework for action. |
| 264 | 1|aOttawa, ON : |bInnovation, Science and Economic Development Canada = Innovation, sciences et développement économique Canada, |cDecember 2022. |
| 264 | 4|c©2022 |
| 300 | |a1 online resource (51 pages) |
| 336 | |atext|btxt|2rdacontent |
| 337 | |acomputer|bc|2rdamedia |
| 338 | |aonline resource|bcr|2rdacarrier |
| 500 | |aCover title. |
| 500 | |aIssued also in French under title: Le syndrome post-COVID-19 au Canada : état des connaissances et cadre d'action. |
| 504 | |aIncludes bibliographical references. |
| 520 | |a"The COVID pandemic has had devastating effects on our society and on human health and mortality. Over the past two years, evidence has emerged to suggest that the impacts of COVID-19 extend beyond the acute phase of the disease which, in some infected individuals, can turn into a chronic illness. In Canada, as of August 2022, more than 1.4 million people – or about 15 percent of adults who have contracted COVID-19 – say they experience symptoms three months or more after their initial SARS-CoV-2 virus infection. These include respiratory, cardiovascular, neurological and cognitive impairments and they can be debilitating"--Executive summary, page 2. |
| 650 | 0|aCOVID-19 (Disease)|xDiagnosis|zCanada. |
| 650 | 0|aCOVID-19 (Disease)|xTreatment|zCanada. |
| 650 | 0|aCOVID-19 Pandemic, 2020-2023|xHealth aspects|zCanada. |
| 650 | 0|aChronic diseases|zCanada. |
| 710 | 1 |aCanada. |bInnovation, Science and Economic Development Canada, |eissuing body. |
| 775 | 08|tLe syndrome post-COVID-19 au Canada : |w(CaOODSP)9.919144 |
| 856 | 40|qPDF|s1.39 MB|uhttps://publications.gc.ca/collections/collection_2023/isde-ised/Iu37-37-2023-eng.pdf |
| 856 | 4 |qHTML|sN/A|uhttps://science.gc.ca/site/science/en/office-chief-science-advisor/initiatives-covid-19/post-covid-19-condition-canada-what-we-know-what-we-dont-know-and-framework-action-pre-report |